Introduction
============

PIWI-interacting RNAs (piRNAs) are germline-specific small RNAs that function in RNA silencing. In *Drosophila*, piRNAs arise mostly from transposable elements and associate with germline-specific Argonaute proteins (PIWI proteins), Aubergine (Aub), Piwi, and Ago3, to guide PIWI proteins to their targets (Saito et al., [@B28], [@B26]; Vagin et al., [@B35]; Aravin et al., [@B1]; Brennecke et al., [@B4]; Gunawardane et al., [@B8]; Nishida et al., [@B22]). Mutations in the *piwi* genes lead to de-repression of transposable elements (Cox et al., [@B5]; Schmidt et al., [@B29]; Vagin et al., [@B34]; Kalmykova et al., [@B11]; Klattenhoff et al., [@B13]; Li et al., [@B14]). Mutations in the piRNA-producing genomic loci, the piRNA clusters, show a similar phenotype (Brennecke et al., [@B4]). Thus, both PIWI and piRNAs are necessary for transposon silencing in the germline. Through this mechanism, the PIWI--piRNA complex, also called the piRNA-induced silencing complex (piRISC), protects the integrity of the germline genome from invasive transposable DNA elements and ensures oogenesis and spermatogenesis.

PIWI-interacting RNAs are produced through two mechanisms, the primary processing pathway and the amplification loop (or the Ping-Pong cycle; Aravin et al., [@B1]; Brennecke et al., [@B4]; Gunawardane et al., [@B8]; Li et al., [@B14]; Malone et al., [@B18]; Siomi et al., [@B31]). Primary piRNAs are first produced through the primary processing pathway; then, the majority of primary piRNAs are amplified by the Ping-Pong cycle to maintain a high expression level of piRNAs in the germline. Maternally deposited piRNAs also serve as primary piRNAs to induce the Ping-Pong cycle in embryos.

Primary piRNAs are mostly antisense to transposon mRNAs, show a strong bias for uracil at the 5′ end (1U bias) and are favorably loaded onto Aub and Piwi (Li et al., [@B14]; Malone et al., [@B18]). Primary piRNAs in ovarian somatic cells require the *female sterile (1)* *Yb* (*Yb*) gene for their accumulation (Olivieri et al., [@B23]; Saito et al., [@B27]; Qi et al., [@B25]). *Yb* is necessary for self-renewal of germline and somatic stem cells in ovaries (Szakmary et al., [@B32]). Germ cells do not express *Yb* and, therefore, *Yb* is unnecessary for primary piRNA production in germ cells. Z*ucchini* (*zuc*) and *armitage* (*armi*) are necessary for primary piRNA production in both ovarian somas (Haase et al., [@B9]; Olivieri et al., [@B23]; Saito et al., [@B27]) and germ cells (Malone et al., [@B18]). *Vasa*, *maelstrom* (*mael*), *krimper* (*krimp*), *armi*, and *spindle-E* (*spn-E*) are necessary for primary piRNA accumulation in testes (Nagao et al., [@B20]). Other genes necessary for primary piRNA production remain elusive.

The Ping-Pong cycle performs piRNA amplification and transposon silencing, simultaneously; this is because transposon mRNAs serve as substrates for the Aub--piRNA complexes. The Aub-Slicer activity, the endonuclease activity required for cleaving the target mRNAs (Gunawardane et al., [@B8]; Nishida et al., [@B22]), determines the 5′ end of mature piRNAs in the sense orientation. Mature piRNAs are then loaded onto Ago3. Thus, Ago3-associating piRNAs are mostly in the sense orientation. The Ago3--piRNA complex, in turn, cleaves antisense transcripts of transposons and the resultant piRNAs are loaded onto Aub. Other factors required for the amplification loop include Vasa, Tudor (Tud), Krimp, Spn-E, and Mael (Findley et al., [@B6]; Lim and Kai, [@B15]; Malone et al., [@B18]).

Tud is one of the Tud domain-containing proteins expressed in fly gonads (Boswell and Mahowald, [@B3]; Thomson and Lasko, [@B33]; Arkov et al., [@B2]). The Tud domains in Tud specifically interact with the symmetrical dimethylarginines (sDMAs) in Aub and Ago3 (Kirino et al., [@B12]; Nishida et al., [@B21]; Liu et al., [@B16],[@B17]; Siomi et al., [@B30]). The association between Tud and Aub or Ago3 occurs simultaneously and the Tud--Aub--Ago3 complex contains piRNA intermediate-like RNA molecules but, in the complex, Aub and Ago3 are free from mature piRNAs. Thus, Tud might serve as a platform for the amplification loop (Nishida et al., [@B21]). Spn-E has a Tud domain (Gillespie and Berg, [@B7]; Ponting, [@B24]); however, it does not seem to associate with Aub and Ago3 (Nishida et al., [@B21]). Krimp also contains a Tud domain (Lim and Kai, [@B15]). Whether Krimp has the ability to associate with PIWI members through their sDMAs remains undetermined.

Until now, the piRNA biogenesis factors that have been identified in *Drosophila* are localized in the cytoplasm and are preferentially accumulated in specific cytoplasmic perinuclear structures, the nuage, and Yb bodies in germ and somatic cells, respectively. Hence, both nuage and Yb bodies are considered to be the locations for piRNA biogenesis (Findley et al., [@B6]; Lim and Kai, [@B15]; Olivieri et al., [@B23]; Saito et al., [@B27]; Qi et al., [@B25]; for review see Siomi et al., [@B31]). Zuc is localized to mitochondria (Olivieri et al., [@B23]; Saito et al., [@B27]). How Zuc localization to mitochondria is mechanistically involved in piRNA biogenesis remains unknown.

Accumulated evidence has shown that in ovaries, nuage localization of the piRNA factors occurs in a molecular hierarchical fashion. The current understanding is that Vasa, a DEAD-box RNA helicase that is detected specifically in the germ cells, is the first to be located to the nuage (Findley et al., [@B6]): Vasa localization is followed by Spn-E, Aub, Ago3, and Mael. Whether this hierarchy is female-specific or occurs also in males remains unexamined. To address this question, we performed immunofluorescence analyses using monoclonal antibodies against individual piRNA factors and found that the nuage localization hierarchy was gender-specific; an obvious difference was seen for Krimp. Krimp is placed between Aub and Ago3 in ovaries, but is placed at the same level with Aub, but upstream of Ago3 in testes. These results suggest that the functional requirement of Krimp in piRNA biogenesis may be different between male and female gonads.

Materials and Methods
=====================

*Drosophila* strains
--------------------

The *yellow white* (*y w*) and *Oregon-R* strains were used as *wild-type* (*wt*) strains. The *tud* allele used was *tud^1^* *bw sp/CyO* *l(2)DTS513^1^* (*Drosophila* Genetic Resource Center stock number: 106505). The *aub* alleles used were *aub^HN2^ cn bw/CyO* and *aub^QC42^ cn bw/CyO*. *aub^HN2^ cn bw/CyO* and *aub^QC42^cn bw/Cy*O were crossed to yield *aub* heterozygous mutant flies; *aub^QC42^/aub^HN2^* (Nishida et al., [@B22]). The *ago3* alleles used were *ago3^t2^/TM6B Tb* and *ago3^t3^/TM6B Tb*. *ago3^t2^/TM6B Tb* and *ago3^t3^/TM6B Tb* were crossed to yield *ago3* heterozygous mutant flies; *ago3^t2^/ago3^t3^* (Li et al., [@B14]). The *krimp* allele used was *w^1118^*; *PBac{WH}krimp^f06583^/CyO* (Bloomington *Drosophila* Stock Center; 18990). *w^1118^*; *PBac{WH}krimp^f06583^/CyO* and *w^1118^; Df(2R)BSC309/CyO* (Bloomington *Drosophila* Stock Center; 23692) were crossed to yield *krimp* transheterozygote mutant flies; *krimp^f06583^/Df*. Transheterozygotes *krimp^f06583^/Df* exhibited male and female sterility and an extent of loss in *krimp* perinuclear staining similar to that exhibited by homozygous *krimp^f06583^* (Lim and Kai, [@B15], and data not shown). Hence, *krimp^f06583^* was used as a loss-of-function allele to characterize *krimp* phenotypes in this study. All stocks were maintained at 25°C.

Production of antibodies and western blotting
---------------------------------------------

An anti-Tudor monoclonal antibody was raised specifically against the C-terminus of the protein. A 327 amino acid fragment at the C-terminal end of Tudor (amino acid 2189 to the end) was fused with glutathione *S*-transferase (GST) and used to immunize mice. An anti-Krimp monoclonal antibody was raised specifically against the N-terminus of the protein. A 200 amino acid fragment at the N-terminal end of Krimp was fused with GST and used to immunize mice. Anti-Tudor and anti-Krimp monoclonal antibodies were produced essentially as described previously (Ishizuka et al., [@B10]) and purified from culture supernatant of hybridoma cells under standard procedures using Thiophilic-Superflow resin (BD Biosciences). Western blot analysis was performed as described previously (Miyoshi et al., [@B19]). Anti-Aub and anti-Ago3 antibodies were used as described previously (Nishida et al., [@B22], [@B21]).

Immunohistochemistry
--------------------

Testes and ovaries were stained with the various antibodies as previously described (Nishida et al., [@B22]; Nagao et al., [@B20]). An anti-Aub antibody was directly labeled using the HiLyte Fluor 555 Labeling Kit-NH2 (Dojindo Molecular Technologies). Anti-Ago3 (1:5,000 dilution; Nagao et al., [@B20]), anti-Tud (1:250 dilution; Nishida et al., [@B21]), and anti-Krimp (1:250 dilution) antibodies were used as primary antibodies. Alexa 488-conjugated or Alexa 546-conjugated anti-mouse IgG (Molecular Probes; 1:1,000 dilution) were used as secondary antibodies. DNA was stained with DAPI. All images were collected using a confocal microscope (Zeiss LSM5 EXCITER). All immunohistochemical analyses were performed at least three times and representative images are shown in the figures.

Results and Discussion
======================

To ensure that we had a constant supply of anti-Tud and anti-Krimp antibodies for this study, we produced Tud and Krimp monoclonal antibodies. We used recombinant Tud and Krimp peptide fragments expressed in and purified from *E. coli* to immunize mice. Western blotting of total ovary and cultured Schneider 2 (S2) lysates showed that the antibodies reacted with proteins of the expected sizes of Tud and Krimp (Figures [1](#F1){ref-type="fig"}A,B, respectively). The Tud band in S2 lysate migrated slightly faster than that in ovary lysate (Figure [1](#F1){ref-type="fig"}A). This may reflect post-translational modification of Tud protein, although clear evidence for this is still required. We also performed western blotting on *tud* and *krimp* mutant ovaries (Figures [1](#F1){ref-type="fig"}A,B). The bands corresponding to Tud and Krimp were not present in the mutants, indicating a high specificity of the antibodies for the individual antigens.

![**Specificity of anti-Tud and anti-Krimp antibodies**. **(A)** Western blotting was performed on Schneider 2 (S2) and total ovary lysates using an anti-Tud monoclonal antibody raised in our laboratory. A band of the size predicted for Tud was detected in both lysates. In *tud* mutant (*tud^1^/tud^1^*) ovaries, the bands corresponding to Tud disappeared, indicating that the antibody was specific to the antigen. Tubulin was used as a loading control. **(B)** Western blotting was performed on S2 and total ovary lysates using an anti-Krimp monoclonal antibody. A band of the size predicted for Krimp was detected. In *krimp* mutant (*krimp^f06583^/Df*) ovaries, the bands corresponding to Krimp disappeared, indicating that the antibody was specific to Krimp.](fgene-02-00055-g001){#F1}

We previously examined the subcellular localization of Tud in *aub* mutant ovaries using an anti-Tud antibody that was a kind gift from A. Nakamura (CDB-RIKEN, Japan; Nishida et al., [@B21]). Here, we used the newly produced anti-Tud antibody to repeat this immunofluorescence study on both control and *aub* mutant ovaries. Very little Tud was localized to the nuage when Aub was not expressed (Figure [2](#F2){ref-type="fig"}A), confirming the previous observation that Aub is necessary for Tud nuage localization (Nishida et al., [@B21]). Tud localization has not been previously examined in *ago3* mutant ovaries. We immunostained for Tud in *ago3* mutant ovaries and detected Tud in the nuage (Figure [2](#F2){ref-type="fig"}A), suggesting that Ago3 is dispensable for Tud nuage localization. Thus, the nuage localization of Aub, but not of Ago3, is necessary for Tud nuage localization. Aub localization to nuage is not affected by loss of *ago3* expression (Figure [2](#F2){ref-type="fig"}A), although Ago3 localization to nuage is affected by loss of *aub* expression (Figure [2](#F2){ref-type="fig"}A). Hence, for nuage localization, Ago3 requires Aub but Aub does not require Ago3.

![**Tud subcellular localization in *aub* and *ago3* mutant ovaries and testes**. **(A)** Ovaries: the control **(a)**, and *aub* (*aub^HN2^/aub^QC42^*) **(b)**, and *ago3* (*ago3^t2^/ago3^t3^*) **(c)** mutant ovaries were stained with anti-Tud antibody; the control **(d)**, and *aub* (*aub^HN2^/aub^QC42^*) **(e)** *ago3* (*ago3^t2^/ago3^t3^*) **(f)** mutant ovaries were stained with anti-Aub antibody; and the control **(g)**, and *aub* (*aub^HN2^/aub^QC42^*) **(h)**, and *ago3* (*ago3^t2^/ago3^t3^*) **(i)** mutant ovaries were stained with anti-Ago3 antibody. Scale bars in all ovary images indicate 10 μm. **(B)** Testes: the control **(a)**, and *aub* (*aub^HN2^/aub^QC42^*) **(b)**, and *ago3* (*ago3^t2^/ago3^t3^*) **(c)** mutant testes were stained with anti-Tud antibody. Enlarged images of the regions that are boxed with white dotted lines in **(B)** **(a--c)** are shown in **(B)** **(d--f)**, respectively. The control **(g)**, and *aub* (*aub^HN2^/aub^QC42^*) **(h)**, and *ago3* (*ago3^t2^/ago3^t3^*) **(i)** mutant testes were stained with anti-Aub antibody; and the control **(j)**; and *aub* (*aub^HN2^/aub^QC42^*) **(k)**; and *ago3* (*ago3^t2^/ago3^t3^*) **(l)** mutant testes were stained with anti-Ago3 antibody. Scale bars in all testis images indicate 20 μm. All immunohistochemical analyses were performed at least three times and representative images are shown.](fgene-02-00055-g002){#F2}

We then examined the subcellular localization of Tud in *aub* and *ago3* mutant testes. The Tud signal was detected in the nuage in *ago3* mutant testes (Figure [2](#F2){ref-type="fig"}B) the same as in control. In *aub* mutant testes, however, the Tud signal was hardly detected in the nuage; instead, it appeared to be in the nucleus in particular in spermatogonia cells (Figure [2](#F2){ref-type="fig"}B). These results suggest that Aub controls the Tud nuage localization even in testes. Aub was localized to the nuage in *ago3* testes (Figure [2](#F2){ref-type="fig"}B), confirming that Aub nuage localization does not require Ago3 in both female and male gonads. Ago3 is not localized to nuage in *aub* mutant testes (Figure [2](#F2){ref-type="fig"}B). Thus, Ago3 nuage localization requires Aub in both males and females.

We then investigated how the subcellular localization of Aub and Ago3 was affected by loss of *tud* function. In ovaries, Aub was detected only slightly in the nuage in *tud* mutant flies (Figure [3](#F3){ref-type="fig"}A), as has been reported previously (Nishida et al., [@B21]). In contrast, Ago3 was localized to the nuage, the same as in the control. These results suggest that under conditions where *tud* function is absent, Ago3 finds an alternative way to be localized to the nuage in a Tud-independent manner. Another possible interpretation is that a small amount of Aub in the nuage is sufficient for Ago3 to be localized to the nuage. Also in testes, Ago3 localization was barely affected by loss of *tud* function, whereas Aub localization was drastically changed (Figure [3](#F3){ref-type="fig"}B); Aub was sparsely localized in the nuage and instead was dispersed in the cytosol. These results indicate that the requirement and dispensability of Tud for nuage localization of Aub and Ago3, respectively, are similar in male and females.

![**Loss of *tud* function affects the subcellular localization of Aub and Ago3 in ovaries and testes similarly**. **(A)** Ovaries: *tud* heterozygous and homozygous mutant ovaries were immunostained with anti-Tud, anti-Aub, and anti-Ago3 antibodies \[**(a)**: *tud* hetero/anti-Tud; **(b)**: *tud* homo/anti-Tud; **(c)**: *tud* hetero/anti-Aub; **(d)**: *tud* homo/anti-Aub; **(e)**: *tud* hetero/anti-Ago3; **(f)**: *tud* homo/anti-Ago3\]. Scale bars in all ovary images indicate 10 μm. **(B)** Testes: *tud* mutant and control testes were immunostained with anti-Aub and anti-Ago3 antibodies \[**(a)**: *tud* hetero/anti-Aub; **(b)**: enlarged image of the region boxed with a white line in **(a)**; **(c)**: *tud* homo/anti-Aub; **(d)**: enlarged image of indicated region in **(c)**; **(e)**: *tud* hetero/anti-Ago3; **(f)**: enlarged image of indicated region in **(e)**; **(g)**: *tud* homo/anti-Ago3; **(h)**: enlarged image of indicated region in **(g)**\]. Scale bars in all testis images indicate 20 μm. All immunohistochemical analyses were performed at least three times and representative images are shown.](fgene-02-00055-g003){#F3}

We also examined how loss of *krimp* affects the localization of Aub and Ago3 in the germline. In *krimp* mutant ovaries, Ago3 lost its ability to localize to the nuage, although Aub was accumulated in the nuage the same as in the control (Figure [4](#F4){ref-type="fig"}A). Thus, Krimp is necessary for nuage localization of Ago3, but not of Aub. Tud nuage localization was maintained even after *krimp* expression was lost (Figure [4](#F4){ref-type="fig"}A). In contrast, in *krimp* mutant testes, Aub, Ago3, and Tud nuage localization was abolished (Figure [4](#F4){ref-type="fig"}B). The requirement of Krimp for Aub and Tud nuage localization is different in ovaries and testes.

![**Loss of *krimp* function affects the subcellular localization of Aub and Ago3 in ovaries and testes differently**. **(A)** Ovaries: the control and *krimp* mutant ovaries were immunostained with anti-Aub, anti-Ago3, and anti-Tud antibodies \[**(a)**: control/anti-Aub; **(b)**: *krimp* mutant/anti-Aub; **(c)**: enlarged image of the part boxed with a white line in **(b)**; **(d)**: control/anti-Ago3; **(e)**: *krimp* mutant/anti-Ago3; **(f)**: enlarged image of indicated region in **(e)**; **(g)**: control/anti-Tud; **(h)**: *krimp* mutant/anti-Tud; **(i)**: enlarged image of indicated region in **(h)**\]. Scale bars in all ovary images indicate 10 μm. **(B)** Testes: the control and *krimp* mutant testes were immunostained with anti-Aub, anti-Ago3, anti-Tud, and anti-Krimp antibodies \[**(a)**: control/anti-Aub; **(b)**: *krimp* mutant/anti-Aub; **(c)**: control/anti-Ago3; **(d)**: *krimp* mutant/anti-Ago3; **(e)**: control/anti-Tud; **(f)**: *krimp* mutant/anti-Tud; **(g)**: control/anti-Krimp; **(h)**: *krimp* mutant/anti-Krimp\]. Scale bars in all testis images indicate 20 μm. All immunohistochemical analyses were performed at least three times and representative images are shown.](fgene-02-00055-g004){#F4}

An earlier study showed that Krimp is localized to the nuage in ovaries (Lim and Kai, [@B15]). In the present study, we confirmed this localization (Figure [5](#F5){ref-type="fig"}A) using our newly produced anti-Krimp antibody (Figure [1](#F1){ref-type="fig"}B). We then examined by immunostaining of ovaries and testes how Krimp nuage localization is affected by loss of other piRNA factors. We found that loss of *ago3* and *tud* expression in ovaries did not affect Krimp localization (Figure [5](#F5){ref-type="fig"}A). However, in *aub* mutant ovaries, Krimp signals were hardly detected in the nuage; instead, Krimp accumulated to unknown cytoplasmic structures (Figure [5](#F5){ref-type="fig"}A). Thus, Aub, but not Ago3 or Tud, is required for Krimp nuage localization. Why Krimp accumulates in cytoplasmic structures remains unknown. The Krimp signal of immunostaining was lower in *aub* and *tud* mutant testes than that in the control, while Krimp expression was unchanged by loss of *ago3* expression (Figure [5](#F5){ref-type="fig"}B). Western blotting confirmed a severe reduction in the expression level of Krimp in *aub* and *tud* mutant testes (Figure [5](#F5){ref-type="fig"}C). Thus, the requirement of Tud in Krimp nuage localization is different between males and females. Why loss of *aub* and *tud* expression causes a severe reduction in the Krimp expression requires further investigation. Krimp was hardly detected in the *tud* mutant testes. However, Ago3 was able to accumulate in the nuage, possibly because Aub was, at least partially, localized to the nuage in *tud* mutant testes. It could be postulated that Ago3 nuage localization necessitates either Aub or Krimp in the nuage.

![**Krimp nuage localization in the piRNA mutant ovaries and testes**. **(A)** Ovaries: the control **(a)** and *aub (b), ago3 (c)*, and *tud (d)* mutant ovaries were immunostained with an anti-Krimp antibody. Scale bars in all ovary images indicate 10 μm. **(B)** Testes: the control **(a)** and *aub (b), ago3 (c)*, and *tud (d)* mutant testes were immunostained with an anti-Krimp antibody. **(C)** Western blotting shows that the expression of Krimp is hardly detected in *aub* and *tud* mutant testes. Scale bars in all testis images indicate 20 μm. All immunohistochemical analyses were performed at least three times and representative images are shown.](fgene-02-00055-g005){#F5}

The nuage localization of piRNA factors, Aub, Tud, Krimp, and Ago3, in ovaries and testes from *wt* and the piRNA factor mutant flies was summarized (Figure [6](#F6){ref-type="fig"}A) and their molecular hierarchy was compared (Figure [6](#F6){ref-type="fig"}B). Their expression patterns in *wt* ovary and testis were also summarized (Figure [6](#F6){ref-type="fig"}C). An obvious difference in the hierarchy is the location of Krimp between Aub and Ago3 in ovaries but at the same level as Aub and upstream of Ago3 in testes. Krimp expression in testis is limited to developmentally early stage cells, such as germline stem cells, gonialblasts, and spermatogonia (Figure [6](#F6){ref-type="fig"}C) and this may be the cause of the gender difference observed in the location of Krimp in the molecular hierarchy.

![**Molecular hierarchy of the piRNA factors in their localization to nuage in ovaries and testes**. **(A)** The nuage localization of piRNA factors, Aub, Tud, Krimp, and Ago3 in *wild-type* (*wt*) and their mutant ovaries and testes: n.d.: none detected. Since none of the piRNA factors in this figure were detected in the nucleus of *wt* ovaries and testes, therefore they were considered to be cytoplasmic proteins. In *tud* mutant ovaries and testes, Aub is only weakly accumulated in the nuage; thus, the nuage is indicated with a thinner line. The Krimp signals are hardly detected in *aub* and *tud* mutant testes. **(B)** The nuage localization hierarchy: Aub is placed upstream of Ago3 in both ovaries and testes. However, Krimp shows gender-specificity; in ovaries Krimp lies between Aub and Ago3, in testes Krimp is placed at the same level as Aub in testes. Tud is required for Aub localization in both male and female nuage. However, Ago3 can be localized to the nuage without *tud* function in both males and females. It is likely that Ago3 nuage localization occurs in both Aub-dependent and Tud-independent manners. **(C)** The expression patterns of Aub, Tud, Krimp, and Ago3 in ovaries and testes. GSCs, germline stem cells; CBs, cystoblasts; NCs, nurse cells; Oo, oocyte; GBs, goniablasts; SG, spematogonia.](fgene-02-00055-g006){#F6}

We reported previously that, in testes, Ago3 functions in the amplification loop with Aub for producing transposon-derived piRNAs (Nagao et al., [@B20]). However, most Ago3-associated testis piRNAs corresponding to *Suppressor* *of* *Stellate* \[*Su*(*Ste*)\] genes that function in silencing the *Stellate* gene, are antisense-oriented and are also detected in piRNAs associated with Aub (Nagao et al., [@B20]). In addition, the vast majority of Ago3-associated piRNAs derived from the *AT-chX* locus on chromosome X, some of which may function in silencing *vasa*, are also antisense-oriented and are found among Aub-associated piRNAs (Nagao et al., [@B20]). The piRNAs that show characteristics similar to those of *AT-chX* and *Su*(*Ste*) piRNAs have so far not been found in ovaries (Nagao et al., [@B20]). Our current finding, that Krimp is located in a different position in the nuage localization hierarchy in ovaries and testes, may further support the idea that some mechanisms of piRNA biogenesis differ in ovaries and testes. Our interpretation is that Krimp may be one of the important factors for producing *AT-chX* and *Su*(*Ste*) primary piRNAs and may enabling their loading into not only Aub, but also Ago3, in testes. In ovaries, Krimp is placed between Aub and Ago3 in the hierarchy and this may be why primary piRNAs are specifically loaded into Aub, but not into Ago3. Krimp has a Tud domain and, thus, it is reasonable to postulate that Krimp associates with Aub and/or Ago3 through their sDMA modifications in both ovaries and testes. However, the mode of their associations could be different in the two tissues: the extent of sDMA modification of Aub and Ago3 may be different and/or the sDMA requirements in the association between Krimp and Aub/Ago3 may be different. These possible differences could be the cause of the gender difference for Krimp in the piRNA factor hierarchy. We are currently investigating the biochemical function of Krimp in piRNA biogenesis and its relationship with Aub and Ago3, as well as the modification status of Aub and Ago3 in both ovaries and testes, which will help further our understanding of piRNA biogenesis in general and of the gender differences in the molecular mechanisms in particular.

We thank T. Okada, A. Shibuya, M. Komai, and H. Kotani for technical assistance and other members of the Siomi laboratory for discussions and comments on the manuscript. This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to Kazumichi M. Nishida, Kaoru Sato, Haruhiko Siomi, and Mikiko C. Siomi. Mikiko C. Siomi is supported by Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST).

[^1]: Edited by: Muller Fabbri, The Ohio State University, USA

[^2]: Reviewed by: Patrick Provost, Université Laval, Canada; Francesca Fanini, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Italy; Michael Frohman, Stony Brook University, USA

[^3]: ^†^Akihiro Nagao and Kaoru Sato have contributed equally to this work.

[^4]: This article was submitted to Frontiers in Non-Coding RNA, a specialty of Frontiers in Genetics.
